TNF-α Limits Serological Memory by Disrupting the Bone Marrow Niche

Copyright © 2023 by The American Association of Immunologists, Inc..

Both infection and autoimmune disease can disrupt pre-existing Ab titers leading to diminished serological memory, yet the underlying mechanisms are not well understood. In this article, we report that TNF-α, an inflammatory cytokine, is a master regulator of the plasma cell (PC) niche in the bone marrow (BM). Acute rTNF-α treatment depletes previously existing Ab titers after vaccination by limiting PC occupancy or retention in the BM. Consistent with this phenomenon, mice lacking TNF-α signaling have elevated PC capacity in the BM and higher Ab titers. Using BM chimeric mice, we found that PC egress from the BM is regulated in a cell-extrinsic manner, by radiation-resistant cells via TNF-α receptor 1 signaling, leading to increased vascular permeability and CD138 downregulation on PCs. PC motility and egress in the BM are triggered within 6 h of recombinant TNF-α treatment. In addition to promoting egress, TNF-α signaling also prevented re-engraftment into the BM, leading to reduced PC survival. Although other inflammatory stimuli can promote PC egress, TNF-α signaling is necessary for limiting the PC capacity in the BM. Collectively, these data characterize how TNF-α-mediated inflammation attenuates the durability of serological memory and shapes the overall size and composition of the Ab-secreting cell pool in the BM.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:210

Enthalten in:

Journal of immunology (Baltimore, Md. : 1950) - 210(2023), 5 vom: 01. März, Seite 595-608

Sprache:

Englisch

Beteiligte Personen:

Aaron, Tonya [VerfasserIn]
Laudermilch, Ethan [VerfasserIn]
Benet, Zachary [VerfasserIn]
Ovando, Luis Jose [VerfasserIn]
Chandran, Kartik [VerfasserIn]
Fooksman, David [VerfasserIn]

Links:

Volltext

Themen:

Immunologic Factors
Journal Article
Research Support, N.I.H., Extramural
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 09.03.2023

Date Revised 02.03.2024

published: Print

Citation Status MEDLINE

doi:

10.4049/jimmunol.2200053

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM351562346